Before they fell into disfavor, legally independent affiliates of biotech companies—special purpose entities—had supported the development of several blockbuster drugs. Are they about to stage a comeback?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Recombinant Capital. Year-end '98 financing numbers: A Tale of Two Biotechs. Signals Magazine, (http://www.signalsmagazine.com) February 7, 1999.
Ernst & Young LLP. Convergence: Ernst and Young's Biotechnology Industry Report, Millennium Edition (Ernst & Young, New York, 2000).
Solt, M.E. SWORD financing of innovation in the biotechnology industry. Financial Management 22, 173–187 (1993).
Edwards, M. et al. Value creation and sharing among universities, biotechnology and pharma. Nat. Biotechnol. 21, 618–624 (2003).
Financial Accounting Standards Board. Exposure Draft, Proposed Interpretation: Consolidation of Certain Special Purpose Entities, an interpretation of ARB NO. 51, File ref. no. 1082-200 (FASB, Norwalk, CT, June 28, 2002).
Acknowledgements
The authors would like to thank the two dozen executives, investment bankers, investors and accountants who generously gave their time and shared their opinions in the interviews that form the basis for much of this research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schiff, L., Murray, F. Biotechnology financing dilemmas and the role of special purpose entities. Nat Biotechnol 22, 271–277 (2004). https://doi.org/10.1038/nbt0304-271
Issue Date:
DOI: https://doi.org/10.1038/nbt0304-271
This article is cited by
-
A better prescription for drug-development financing
Nature Biotechnology (2007)
-
A reprise for collaborative financing in biotech
Nature Biotechnology (2006)